Early Dipyridamole 99m Tc-Sestamibi Single Photon Emission Computed Tomographic Imaging 2 to 4 Days After Acute Myocardial Infarction Predicts In-Hospital and Postdischarge Cardiac Events
- 16 November 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (20), 2060-2066
- https://doi.org/10.1161/01.cir.100.20.2060
Abstract
Background—Because of its brief hemodynamic effects and minor effect on determinants of myocardial oxygen demand, vasodilator stress myocardial perfusion imaging (MPI) can be applied very early after acute myocardial infarction (AMI) for risk stratification, allowing management decisions to be made earlier and thus potentially shortening hospitalization stays, reducing costs, and preventing early cardiac events. This multicenter randomized trial compared the prognostic value of early dipyridamole MPI and standard predischarge submaximal exercise MPI in patients who presented with AMI. Methods and Results—Patients who presented with their first AMI (n=451) were randomized in a 3:1 ratio to undergo either both an early (day 2 to 4) dipyridamole 99mTc-sestamibi MPI study and a predischarge (day 6 to 12) submaximal exercise 99mTc-sestamibi MPI study or only the predischarge study. Multivariate predictors of in-hospital cardiac events included nuclear imaging summed stress and summed reversibility scores and peak creatine kinase. For postdischarge cardiac events, multivariate predictors in patients undergoing dipyridamole MPI included only the summed stress, reversibility, and rest imaging scores and anterior MI. For a given summed stress score, the interaction of reversibility score further improved the predictive value. Dipyridamole MPI showed better risk stratification than submaximal exercise MPI. Conclusions—Dipyridamole MPI very early after MI predicts early and late cardiac events, with superior prognostic value compared with submaximal exercise imaging. The extent and severity of the stress defect and reversibility of the defect were the most important predictors of cardiac death and recurrent MI. This technique can allow management decisions to be made earlier with regard to AMI patients and could have important economic impact if applied widely.Keywords
This publication has 15 references indexed in Scilit:
- Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management StrategyNew England Journal of Medicine, 1998
- Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarctionAmerican Heart Journal, 1997
- Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysisAmerican Heart Journal, 1995
- Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarctionJournal of the American College of Cardiology, 1995
- Use of exercise technetiumtium-99m sestamibi SPECT imagina to detect residual ischemia and for risk stratification after acute myocardial infarctionThe American Journal of Cardiology, 1995
- Infection of the heart by the human immunodeficiency virusThe American Journal of Cardiology, 1990
- Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic eventsThe American Journal of Cardiology, 1990
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- Prognostic Value of Exercise Testing Soon after Myocardial InfarctionNew England Journal of Medicine, 1979
- Estimation of Infarct Size in Man and its Relation to PrognosisCirculation, 1972